Tilray Brands (TLRY) Cash from Operations (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Cash from Operations (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -70.10% |
| Feb 28, 2026 | -157.02% |
| Nov 30, 2025 | -536.61% |
| Aug 31, 2025 | 89.53% |
| May 31, 2025 | -122.31% |
| Feb 28, 2025 | 85.85% |
| Nov 30, 2024 | -15.34% |
| Aug 31, 2024 | -214.98% |
| May 31, 2024 | 299.90% |
| Feb 29, 2024 | 49.49% |
| Nov 30, 2023 | -91.95% |
| Aug 31, 2023 | -136.34% |
| May 31, 2023 | 334.00% |
| Feb 28, 2023 | -163.79% |
| Nov 30, 2022 | 163.13% |
| Aug 31, 2022 | -125.44% |
| May 31, 2022 | 55.76% |
| Feb 28, 2022 | -170.95% |
| Nov 30, 2021 | 81.64% |
| Aug 31, 2021 | -1,230.16% |